Intermittent chronic telogen effluvium with an unusual dermoscopic finding following COVID‐19
Open Access
- 9 August 2022
- journal article
- research article
- Published by Wiley in Clinical Case Reports
- Vol. 10 (8)
Abstract
Various conditions, including infections, can cause telogen effluvium (TE). One of them is coronavirus disease 2019 (COVID‐19), where hair loss usually begins between 2 and 12 weeks after the illness. TE can be acute or chronic, and the chronic type can be intermittent. Here, we present the case of a 17‐year‐old girl with severe and widespread hair loss following an upper respiratory infection suspected to be COVID‐19, with the patient having a history of such attacks since childhood. Evidence from biopsy and dermoscopy indicated a diagnosis of TE.Keywords
This publication has 24 references indexed in Scilit:
- Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the LiteratureDrugs - Real World Outcomes, 2016
- Radiation-induced temporary alopecia after embolization of cerebral aneurysmIndian Journal of Dermatology, 2014
- Hair Shafts in TrichoscopyDermatologic Clinics, 2013
- Telogen effluviumIndian Journal of Dermatology, Venereology and Leprology, 2013
- Lanceolate hair‐J (lahJ): A mouse model for human hair disordersExperimental Dermatology, 2000
- Chronic telogen effluvium: Increased scalp hair shedding in middle-aged womenJournal of the American Academy of Dermatology, 1996
- Acute Alopecia: Clue to Thallium ToxicityPediatric Dermatology, 1993
- Telogen EffluviumArchives of Dermatology, 1993
- Telogen effluvium. New concepts and reviewArchives of Dermatology, 1993
- Pathologic Dynamics of Human Hair LossArchives of Dermatology, 1961